Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials
Related Posts
Minor C, Takayesu A, Arbing MA, Ha SM, Gunsalus RP, Pellegrini M, Sawaya MR, Clubb RT. AlphaFold-driven structural proteomics reveals extensive cellulosome machinery in human[...]
Shafiei-Jahani P, Li X, Akbari A, Vera A, Haniff E, Carlisle R, Akbari O, Holland V. Unraveling the autoimmune architecture of pemphigus: from B-cell depletion[...]
Park A, Kenney S, Kellogg C, Castillo JR, Bergheim T. Cerebriform Ridges on the Scalp Signaling a Tumor in the Brain. Perm J. 2026 Jul[...]